10.1039/d1cs00468a 54 PengS.XiaoF.ChenM.GaoH
J Clin Transl Hepatol 7(1):5660
Benign Prostate Hyperplasia Policy number: M.29 Summary: Covers specific minimally invasive treatments for BPHsuch as prostatic urethral lift (Urolift), water vapor therapy (Rezum), and transurethral waterjet ablationwhen strict clinical criteria are met, while deeming other procedures (e.g., PAE, cryoablation, HIFU) not medically necessary
Frequently asked questions No, GLP-1 patches are sold as dietary supplements and have not been evaluated or approved by the FDA for safety, quality, or effectiveness
Diabetes Therapy 14(4):723736 Do D, Lee T, Peasah SK, Good CB, Inneh A, Patel U (2024) PMPH GLP-1 receptor agonist discontinuation among patients with obesity and/or type 2 diabetes